Skip to main content
Log in

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Haberman RH, et al. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Annals of the Rheumatic Diseases : 25 May 2021. Available from: URL: http://dx.doi.org/10.1136/annrheumdis-2021-220597

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines. Reactions Weekly 1858, 11 (2021). https://doi.org/10.1007/s40278-021-96729-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-96729-4

Navigation